Therapeutic potential of chalcones as cardiovascular agents

详细信息    查看全文

• 作者：Debarshi Kar Mahapatra ; Sanjay Kumar Bharti ; ^{skbharti.ggu@gmail.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：1 ; 4-DHP ; 1 ; 4-dihydropyridyl ; 4-HD ; 4-hydroxyderricin ; AA ; arachidonic acid ; ACAT ; acyl-coenzyme A ; cholesterol acyltransferase ; ACE ; angiotensin converting enzyme ; ADP ; adenosine 5&prime ; -diphosphate ; AngI ; angiotensin I ; AngII ; angiotensin II ; BP ; blood pressure ; CETP ; cholesteryl ester transfer protein ; CHD ; coronary heart disease ; COX-1 ; cyclooxygenase-1 ; CVDs ; cardiovascular diseases ; DGAT ; diacylglycerol acyltransferase ; DRC ; derricin ; ET ; essential thrombocythemia ; HC ; hepatic cholesterol
• 刊名：Life Sciences
• 出版年：2016
• 出版时间：1 March 2016
• 年：2016
• 卷：148
• 期：Complete
• 页码：154-172
• 全文大小：2494 K

文摘

Cardiovascular diseases are the leading cause of death affecting 17.3 million people across the globe and are estimated to affect 23.3 million people by year 2030. In recent years, about 7.3 million people died due to coronary heart disease, 9.4 million deaths due to high blood pressure and 6.2 million due to stroke, where obesity and atherosclerotic progression remain the chief pathological factors. The search for newer and better cardiovascular agents is the foremost need to manage cardiac patient population across the world. Several natural and (semi) synthetic chalcones deserve the credit of being potential candidates to inhibit various cardiovascular, hematological and anti-obesity targets like angiotensin converting enzyme (ACE), cholesteryl ester transfer protein (CETP), diacylglycerol acyltransferase (DGAT), acyl-coenzyme A: cholesterol acyltransferase (ACAT), pancreatic lipase (PL), lipoprotein lipase (LPL), calcium (Ca^2 +)/potassium (K⁺) channel, COX-1, TXA₂ and TXB₂. In this review, a comprehensive study of chalcones, their therapeutic targets, structure activity relationships (SARs), mechanisms of actions (MOAs) have been discussed. Chemically diverse chalcone scaffolds, their derivatives including structural manipulation of both aryl rings, replacement with heteroaryl scaffold(s) and hybridization through conjugation with other pharmacologically active scaffold have been highlighted. Chalcones which showed promising activity and have a well-defined MOAs, SARs must be considered as prototype for the design and development of potential anti-hypertensive, anti-anginal, anti-arrhythmic and cardioprotective agents. With the knowledge of these molecular targets, structural insights and SARs, this review may be helpful for (medicinal) chemists to design more potent, safe, selective and cost effective chalcone derivatives as potential cardiovascular agents.